Excellent Response to Leflunomide in a Case of Large-Vessel Giant Cell Arteritis Demonstrated Simultaneously by Clinical, Laboratory, Ultrasound, and Positron Emission Tomography/Computed Tomography Parameters
- PMID: 32332274
- DOI: 10.1097/RHU.0000000000001393
Excellent Response to Leflunomide in a Case of Large-Vessel Giant Cell Arteritis Demonstrated Simultaneously by Clinical, Laboratory, Ultrasound, and Positron Emission Tomography/Computed Tomography Parameters
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Dejaco C, Duftner C, Buttgereit F, et al. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease. Rheumatology . 2017;56:506–515.
-
- Stone JH, Tuckwell K, Dimonaco S, et al. Trial of tocilizumab in giant-cell arteritis. N Engl J Med . 2017;377:317–328.
-
- Adizie T, Christidis D, Dharmapaliah C, et al. Efficacy and tolerability of leflunomide in difficult to treat polymyalgia rheumatica and giant cell arteritis. Int J Clin Pract . 2012;66:906–909.
-
- Hočevar A, Ješe R, Rotar Ž, et al. Does leflunomide have a role in giant cell arteritis? An open-label study. Clin Rheumatol . 2019;38:291–296.
-
- Dasgupta B, Smith K, Khan A, et al. Slope sign’: a feature of large vessel vasculitis. Ann Rheum Dis . 2019;78:1738.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
